| Mrs Elizabeth Andrachek Perdue, MD | |
|
1250 E Marshall St, Richmond, VA 23298-5051 | |
| (804) 828-9783 | |
| Not Available |
| Full Name | Mrs Elizabeth Andrachek Perdue |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1250 E Marshall St, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790986198 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101243374 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cjw Medical Center | Richmond, VA | Hospital |
| Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcv Associated Physicians | 4385542117 | 1312 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | Emergency Physicians Of Southern Virginia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417187667 PECOS PAC ID: 0345236568 Enrollment ID: O20040422001520 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | United Emergency Services Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326007915 PECOS PAC ID: 5799697272 Enrollment ID: O20040731000104 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | Cmh Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194760645 PECOS PAC ID: 3779551445 Enrollment ID: O20040921000171 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050418000414 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | Richmond Emergency Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134374978 PECOS PAC ID: 7517021652 Enrollment ID: O20090204000205 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Entity Name | Ingleside Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144712662 PECOS PAC ID: 1355698317 Enrollment ID: O20180720002968 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elizabeth Andrachek Perdue, MD Po Box 980257, Richmond, VA 23298-0257 Ph: (804) 828-9783 | Mrs Elizabeth Andrachek Perdue, MD 1250 E Marshall St, Richmond, VA 23298-5051 Ph: (804) 828-9783 |
News Archive
The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.
› Verified 8 days ago
Robert Weisberger, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5801 Bremo Rd, Virginia Emergency Associates Inc, Richmond, VA 23226 Phone: 804-287-7066 Fax: 804-673-9531 | |
Dr. Michael Ferebee, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1602 Skipwith Rd, Richmond, VA 23229 Phone: 757-329-3754 | |
James R Shefferly, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5801 Bremo Rd, Virginia Emergency Associates Inc, Richmond, VA 23226 Phone: 804-287-7066 Fax: 804-673-9531 | |
Jeffry A Zimmerman, P.A. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, St Francis Emergency Department, Richmond, VA 23226 Phone: 804-287-7066 Fax: 804-673-9531 | |
Shawn M Borich, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Rockbridge St Ste 103, Richmond, VA 23230 Phone: 804-386-0200 | |
Tamera Barnes, MD, FACEP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7101 Jahnke Rd, Richmond, VA 23225 Phone: 804-330-2000 | |
Dr. Kevin James Noreika, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1401 Johnston Willis Dr, Richmond, VA 23235 Phone: 804-330-2277 |